RIGEL PHARMACEUTICALS INC (RIGL)
US7665596034 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 32.79M | 24.50M | 18.90M | 30.40M | 22.50M | |||
| Marketable Securities | 24.15M | 33.70M | 106.10M | 27.00M | 75.60M | |||
| Receivables | 30.55M | 40.30M | 15.50M | 16.00M | 10.10M | |||
| Inventories | 5.52M | 9.10M | 6.60M | 1.60M | 1.40M | |||
| Other Current Assets | 6.26M | 8.30M | 7.40M | 14.00M | 9.50M | |||
| Total Current Assets | 99.27M | 115.90M | 154.50M | 89.00M | 119.00M | |||
| Non-Current Assets | ||||||||
| PPE Net | 1.03M | 2.80M | 11.90M | 20.60M | 27.90M | |||
| Intangibles | 13.88M | 14.90M | N/A | N/A | N/A | |||
| Other Non-Current Assets | 3.06M | 600.00K | 1.00M | 800.00K | 700.00K | |||
| Total Non-Current Assets | 17.96M | 18.40M | 12.80M | 21.40M | 28.60M | |||
| TOTAL ASSETS | 117.22M | 134.30M | 167.30M | 110.40M | 147.60M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 7.23M | N/A | N/A | N/A | N/A | |||
| Accrued Expenses | 18.21M | 24.20M | 43.70M | 34.10M | 28.80M | |||
| Accounts Payable | 7.14M | 22.50M | 3.80M | 3.70M | 4.20M | |||
| Other Current Liabilities | 20.68M | 18.50M | 16.10M | 3.00M | 25.30M | |||
| Total Current Liabilities | 53.27M | 65.20M | 63.60M | 40.80M | 58.20M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 52.37M | 39.40M | 19.90M | 19.80M | 9.80M | |||
| Other Non-Current Liabilities | 40.23M | 43.20M | 53.50M | 15.70M | 25.70M | |||
| Total Non-Current Liabilities | 92.60M | 82.70M | 73.40M | 35.60M | 35.60M | |||
| TOTAL LIABILITIES | 145.87M | 147.90M | 137.00M | 76.40M | 93.80M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -1.41B | -1.38B | -1.32B | -1.31B | -1.28B | |||
| Additional Paid In Capital | 1.38B | 1.37B | 1.35B | 1.34B | 1.33B | |||
| Common Shares | 175.00K | 200.00K | 200.00K | 200.00K | 200.00K | |||
| Other Shareholders' Equity | 8.00K | -200.00K | -100.00K | 0.00 | 0.00 | |||
| Shares Outstanding | 174.83M | 173.40M | 171.60M | 169.30M | 168.00M | |||
| Tangible Book Value per Share | -0.24 | -0.16 | 0.18 | 0.20 | 0.32 | |||
| Total Shareholders' Equity | -28.64M | -13.60M | 30.40M | 34.00M | 53.80M | |||
| TOTAL LIABILITIES AND EQUITY | 117.22M | 134.30M | 167.30M | 110.40M | 147.60M | |||
| Statistics | ||||||||
| Debt/Equity | -1.83 | -2.90 | 0.65 | 0.58 | 0.18 | |||
| Current Ratio | 1.86 | 1.78 | 2.43 | 2.18 | 2.04 | |||
| Return On Assets (ROA) | -21.40% | -43.63% | -10.70% | -26.90% | -45.33% | |||
| Return On Equity (ROE) | N/A | N/A | -58.88% | -87.35% | -124.35% | |||
All data in USD